| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3295295 | Gastroenterology | 2009 | 9 Pages |
Abstract
Our results demonstrate that APs are a novel class of antiviral compounds that hold promise as a drug to inhibit HCV entry.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Takuya Matsumura, Zongyi Hu, Takanobu Kato, Marlene Dreux, Yong-Yuan Zhang, Michio Imamura, Nobuhiko Hiraga, Jean-Marc Juteau, Francois-Loic Cosset, Kazuaki Chayama, Andrew Vaillant, T. Jake Liang,